Peer Review History
| Original SubmissionJanuary 31, 2025 |
|---|
|
Dear Dr. Rohacek, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 16 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Abraham Aregay Desta, MSc, PhD candidate. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: [Martin Rohacek received fund from the Else Kröner Fresenius Foundation, Germany, Julie Rossier received funds from the Freiwillige Akatremische Gesellschaft Basel, Switzerland]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The study addresses an important gap in the literature by providing the first detailed description of diagnoses and outcomes in a rural high dependency unit (HDU) in sub-Saharan Africa. The methodology is robust, with a prospective cohort design, clear inclusion/exclusion criteria, and comprehensive data collection. The findings are significant, highlighting high mortality rates and predictors of in-hospital mortality, which have important implications for critical care in low-resource settings. Areas for Improvement: Clarity and Structure: Some sections (e.g., Results, Discussion) could be streamlined for better readability. Contextualization: The paper would benefit from a stronger emphasis on the broader implications of the findings for policy and practice in rural healthcare. Limitations: While limitations are acknowledged, they could be discussed in more depth, particularly regarding the impact of financial constraints and diagnostic limitations on patient outcomes. Language: Minor grammatical and stylistic improvements are needed to enhance clarity and flow. Overall Assessment: The paper is scientifically sound and makes a valuable contribution to the field. The required revisions are relatively minor and primarily focus on improving clarity, structure, and contextualization. Reviewer #2: The study addresses an important gap in understanding critically ill patient outcomes in rural HDUs, making it highly relevant for clinicians and policymakers. Here are my recommendations: 1. The introduction focuses heavily on HDU setup rather than framing a clear research gap. 2. The objective should be explicitly stated earlier in the introduction and aligned more clearly with the research question. 3. The methods section needs more focus on patient selection,sample size, data collection, and statistical analysis rather than HDU implementation details. 4. The criteria for selecting variables in multivariable analysis are not clearly stated. Providing justification based on univariate p-values, clinical relevance, or confounding adjustment would improve transparency. 5. There are inconsistencies in reporting p-values and confidence intervals. Using a uniform format (e.g., p = 0.03, 95% CI 1.07–2.28) would enhance readability. 6. Realign all the segments to the objectives rather and HDU implementation. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Yamlak Gindola Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Abraham Aregay Desta Academic Editor PLOS ONE Additional Editor Comments: Dear Authors, Thank you for submitting your revised manuscript entitled “First Insights into Critical Care Outcomes in a Rural Tanzanian High Dependency Unit: A Prospective Cohort Study” (Manuscript ID: PONE-D-25-05201R1) to PLOS ONE. After careful evaluation of your submission, we appreciate the important contribution your study offers in understanding critical care delivery in a low-resource and rural setting. However, the manuscript still requires major revisions before it can be considered for publication. Below are the primary concerns and suggestions that must be addressed: � Please try to indicate the line number and page while you respond for each comment � Consider modifying your title as “Diagnoses and Critical Care Outcomes in a Rural Tanzanian High Dependency Unit: A Prospective Cohort Study”. Because, despite the “first insights” draws attention, it can lead a bit vague and may loss academic tone. In addition, this title should directly be coherent with the background, objectives and the results as well, you have showed most common diagnoses. � Can you please provide the justification why you conducted multivariable analysis, as you have no sample (you have included all the study participants), or to whom are you going to infer? � In the statistical analysis part for the association between clinical factors, risk scores, and mortality was assessed using Cox proportional hazards regression. However, there is no information how you checked the proportional hazard assumption. You will have meaningful comparisons of risk factors if the assumptions are held. � Better to replace describe by identify in the “to describe predictors of in-hospital mortality” � You have mentioned that Kaplan-Meier survival curves to visualize mortality rate s over time in your feedback however, there is any description about this in your statistical analysis. Additionally, if you used Kaplan-Meier survival curves how do check the effect of the censoring pattern or how do you check the homogeneity of the groups? � Overall, you must show the methods clearly, especially your statistical analysis is not clear and try to improve this section. � Improve your discussion and compare it with some international findings and show the gaps clearly. Rember that you have mentioned “Critical care services in sub-Saharan Africa increased since the COVID-19 pandemic, but remain limited compared to high-income countries” in the introduction part Please revise the manuscript based on the above feedbacks. We also encourage you to include a point-by-point response addressing each concern raised. Highlight all changes in the revised manuscript for easier evaluation. Once we receive your revised submission, we will proceed with further editorial review. We appreciate your efforts in advancing research in global health and look forward to receiving your revised manuscript. Sincerely, Abraham Desta Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Dear Dr. Rohacek, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Abraham Aregay Desta, MSc. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: PONE-D-25-05201R2 Diagnoses and Critical Care Outcomes in a Rural Tanzanian High Dependency Unit: A Prospective Cohort Study PLOS ONE Dear Authors, Thank you for submitting the 2nd round of the revised version of your manuscript entitled "Diagnoses and Critical Care Outcomes in a Rural Tanzanian High Dependency Unit: A Prospective Cohort Study" to PLOS One. We appreciate the time and effort you have invested in addressing the comments provided by the reviewers’ and editor during the previous rounds. after carefully reviewing your updated manuscript and your detailed comments, your work is almost ready for publication. However, we kindly ask that you to address a few items before we move forward with acceptance. These are mostly clarifications or editorial adjustments that should be straightforward to address. We kindly ask that you: • Be transparent the scope of the generalizability as far as you included all the subjects in the sampling • Make uniform editing throughout the manuscript such as line spacing and others • Abstract should be a maximum of 300 words • Revise the manuscript according to the PLOS One guideline • Ensure to provide adequate response to all feedback given by the reviewers and editor • Revise your manuscript considering the comments • Provide a brief point-by-point response to each comment • Highlight all changes made in the manuscript Please submit your revised manuscript within 2 weeks. However, if you need additional time, do not hesitate to contact us. We look forward to receiving your revised submission and moving forward with publication. Regards, Abraham Aregay Desta, MSc, PhD candidate. PLOS ONE Editor [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 3 |
|
Diagnoses and Critical Care Outcomes in a Rural Tanzanian High Dependency Unit: A Prospective Cohort Study PONE-D-25-05201R3 Dear Authors, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Abraham Aregay Desta Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-25-05201R3 PLOS ONE Dear Dr. Rohacek, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Abraham Aregay Desta Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .